View in EDS

Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis.

Saved in:
Bibliographic Details
Title: Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis.
Authors: Chua, Corrine Ying Xuan1, Jain, Priya1, Ballerini, Andrea1, Bruno, Giacomo1, Hood, R. Lyle1, Gupte, Manas1, Gao, Song1, Di Trani, Nicola1, Susnjar, Antonia1, Shelton, Kathryn1, Bushman, Lane R.1, Folci, Marco1, Filgueira, Carly S.1, Marzinke, Mark A.1, Anderson, Peter L.1, Hu, Ming1, Nehete, Pramod1, Arduino, Roberto C.1, Sastry, Jagannadha K.1, Grattoni, Alessandro1 agrattoni@houstonmethodist.org
Source: Journal of Controlled Release. Sep2018, Vol. 286, p315-325. 11p.
Database: Academic Search Ultimate
Description
ISSN:01683659
DOI:10.1016/j.jconrel.2018.08.010